Aaron Gordon
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Aaron Gordon has a total of 31 co-authors. Here are the top co-authors by number of shared publications:
Daniel H. Geschwind
Program in Neurogenetics, Department of Neurology, University of California, Los Angeles, Los Angeles, CA 90095, USA; Department of Human Genetics, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA 90095, USA; Center for Autism Research and Treatment, Semel Institute, University of California, Los Angeles, Los Angeles, CA 90095, USA; Institute of Precision Health, University of California, Los Angeles, Los Angeles, CA 90095, USA
2 shared publications- Min-Yin Li
Department of Psychiatry and Behavioral Sciences, Stanford University, Stanford, USA
2 shared publications - Sergiu P. Pasca
Department of Psychiatry and Behavioral Sciences, Stanford University, Stanford, USA
2 shared publications Alfredo M. Valencia
Department of Psychiatry and Behavioral Sciences, Stanford University School of Medicine, Stanford, CA 94305, USA; Stanford Brain Organogenesis, Wu Tsai Neurosciences Institute, Stanford University, Stanford, CA 94305, USA
1 shared publicationAnca M. Paşca
Department of Human Genetics, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA 90095, USA; Department of Pediatrics, Division of Neonatology, Stanford University, Stanford, CA 94305, USA
1 shared publicationAnna K. Krawisz
Department of Neurobiology, Stanford University, Stanford, USA
1 shared publication
Latest Publications
- Top Cited Papers
- 5 January 2022
- Published by Elsevier in Cell Stem Cell
- Vol. 29 (2) , 248-264.e7
Dissecting the molecular basis of human interneuron migration in forebrain assembloids from Timothy syndrome
- 5 January 2022
- Published by Elsevier in Cell Stem Cell
- Vol. 29 (2) , 248-264.e7
Top Cited PapersDissecting the molecular basis of human interneuron migration in forebrain assembloids from Timothy syndrome
- Top Cited Papers
- 28 September 2020
- Published by Springer Nature in Nature Medicine
- Vol. 26 (12) , 1888-1898
Neuronal defects in a human cellular model of 22q11.2 deletion syndrome
22q11.2 deletion syndrome (22q11DS) is a highly penetrant and common genetic cause of neuropsychiatric disease. Here we generated induced pluripotent stem cells from 15 individuals with 22q11DS and 15 control individuals and differentiated them into three-dimensional (3D) cerebral cortical organoids. Transcriptional profiling across 100 days showed high reliability of differentiation and revealed changes in neuronal excitability-related genes. Using electrophysiology and live imaging, we identified defects in spontaneous neuronal activity and calcium signaling in both organoid- and 2D-derived cortical neurons. The calcium deficit was related to resting membrane potential changes that led to abnormal inactivation of voltage-gated calcium channels. Heterozygous loss of DGCR8 recapitulated the excitability and calcium phenotypes and its overexpression rescued these defects. Moreover, the 22q11DS calcium abnormality could also be restored by application of antipsychotics. Taken together, our study illustrates how stem cell derived models can be used to uncover and rescue cellular phenotypes associated with genetic forms of neuropsychiatric disease.
- 28 September 2020
- Published by Springer Nature in Nature Medicine
- Vol. 26 (12) , 1888-1898
Top Cited PapersNeuronal defects in a human cellular model of 22q11.2 deletion syndrome
22q11.2 deletion syndrome (22q11DS) is a highly penetrant and common genetic cause of neuropsychiatric disease. Here we generated induced pluripotent stem cells from 15 individuals with 22q11DS and 15 control individuals and differentiated them into three-dimensional (3D) cerebral cortical organoids. Transcriptional profiling across 100 days showed high reliability of differentiation and revealed changes in neuronal excitability-related genes. Using electrophysiology and live imaging, we identified defects in spontaneous neuronal activity and calcium signaling in both organoid- and 2D-derived cortical neurons. The calcium deficit was related to resting membrane potential changes that led to abnormal inactivation of voltage-gated calcium channels. Heterozygous loss of DGCR8 recapitulated the excitability and calcium phenotypes and its overexpression rescued these defects. Moreover, the 22q11DS calcium abnormality could also be restored by application of antipsychotics. Taken together, our study illustrates how stem cell derived models can be used to uncover and rescue cellular phenotypes associated with genetic forms of neuropsychiatric disease.